Skip to main content

RT @ericdeinmd: Thieves Market #ACR22 Amoebic arthritis - is it rare? Case from Indonesia After the case, found it in 3

Social Author Name
Eric Dein
Tweet Content
Thieves Market #ACR22 Amoebic arthritis - is it rare? Case from Indonesia After the case, found it in 3 other synovial fluids! Rx with surgery, metronidazole - later rx for post-ifn arthritis and gout @RheumNow https://t.co/oi8PqtTTyc

RT @bella_mehta: Severe subtype of #sJIA HLADRB1*15:01 known to be associated with adverse drug reactions to biologics.

Social Author Name
Bella Mehta
Tweet Content
Severe subtype of #sJIA HLADRB1*15:01 known to be associated with adverse drug reactions to biologics. prospective cohort - 65pts. - Anakinra effective irrespective of HLADRB1*15:01 - No difference in eosinophilia - Recommend not to wait to start tx @rheumnow #ACR22 abst#L12 https://t.co/LX5lMJOKRf

RT @AurelieRheumo: Alert 🚨 New imaging technology MSOT = combination of US and photo acoustic imaging Detects metab

Social Author Name
Aurelie Najm
Tweet Content
Alert 🚨 New imaging technology MSOT = combination of US and photo acoustic imaging Detects metabolites in enthesis and synovitis 🫱🏼>Hb and O2 saturation correlate w/ Doppler+ 🫱🏼>Hb & collagen correlate w/ calcifications https://t.co/X18fGFVh5L Abs#2205 #ACR22 @RheumNow https://t.co/84BU5YUrCz

RT @drdavidliew: RA really does still impact employment outcomes for many, despite T2T. @earlyarthritis🇨🇦 data in

Social Author Name
David Liew
Tweet Content
RA really does still impact employment outcomes for many, despite T2T. @earlyarthritis🇨🇦 data in working age people show many back in the game in the first year, but not many more after that. Plenty more to do to get all our pts back to their best! ABST1967 #ACR22 @RheumNow https://t.co/isD1rgkFoH

RT @RHEUMarampa: SURPASS was a head-to-head study comparing SEC vs ADA biosimilar (SDZ-ADL) in r-axSpA on spinal radio p

Social Author Name
sheila
Tweet Content
SURPASS was a head-to-head study comparing SEC vs ADA biosimilar (SDZ-ADL) in r-axSpA on spinal radio progression: Results showed no significant diff in spinal radio progression bet. the 2 grps. Biosimilars remain tx options for r-axSpA. #ACR22 @RheumNow ABST#L15

RT @JulianSegan: Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ a

Social Author Name
Julian Segan
Tweet Content
Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ active foot involvement have higher scores anyway (driven by physician & patient global) but examining feet would have only changed management in 3.1%. @RheumNow ABST0265 #ACR22 https://t.co/ckuB8R4ZTF

RT @uptoTate: PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose

Social Author Name
Dr. Rachel Tate
Tweet Content
PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose of PCV13 at day 0 and day 7 followed by a single dose of PPV23 at M5. More data needed on this updated, clinical strategy. Abs L16 #ACR22 @RheumNow https://t.co/m71VQMGZ68

Polymyalgia rheumatica: more than just steroids at #ACR22 After decades of having little else proven apart from glucoc

Social Author Name
Dr. John Cush
Tweet Content
Polymyalgia rheumatica: more than just steroids at #ACR22 After decades of having little else proven apart from glucocorticosteroids with which to treat PMR, evidence for steroid-sparing options has grown in recent years. https://t.co/CjMzEqRan8 https://t.co/5UixhVemqY

RT @drdavidliew: SMS/email reminders slightly improve fluvax uptake in RA pts (nested RCT within ART registry, France) A

Social Author Name
David Liew
Tweet Content
SMS/email reminders slightly improve fluvax uptake in RA pts (nested RCT within ART registry, France) ABST2002 #ACR22 @RheumNow @philipcrobinson & I wrote @TheLancetRheum on how to improve preventative med https://t.co/55j8rdv3nV I think we need multiple simultaneous strategies! https://t.co/pNfpWLVkac
Subscribe to
×